8-K current report · filed Oct 30, 2026

OmniAb, Inc. (OABI) 8-K Current Report: October 30, 2026

Item 2.02Item EX-99.1OABI overview

Short answer

OmniAb, Inc. (OABI) filed an 8-K current report with the SEC on October 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). OmniAb reported financial results for Q3 and nine months ended September 30, 2026.

OmniAb, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • OmniAb reported financial results for Q3 and nine months ended September 30, 2026
  • Exhibit 99.1 contains the substantive earnings release and financial details
  • Results furnished under Regulation FD, generally not subject to Section 18 filing liability

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue rose to $4.0M from $2.2M, while net loss narrowed to $15.7M from $16.5M
  • Nine-month revenue reached $31.8M versus $10.3M, driven primarily by $21.6M in license and milestone revenue
  • 2026 revenue guidance increased to $35M-$39M, with year-end cash outlook raised to $53M-$57M
  • Eli Lilly collaboration adds up to $370M in potential milestones plus tiered royalties for a new ion channel program
  • xPloration broader launch targets an estimated market above $500M, with revenue expected at $2M-$3M in 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other OmniAb, Inc. 8-K filings

Get the next OABI 8-K as it lands

Follow OABI for push alerts, or ask the research agent what this filing means.